The predictive power of <scp>FDG‐PET</scp> imaging with regard to immunotherapy in real‐life conditions in advanced melanoma: An exploratory study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The predictive power of FDG‐PET imaging with regard to immunotherapy in real‐life conditions in advanced melanoma: An exploratory study

Published:2022-08-24 Issue:1 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Blanchet Katleen¹,Sebille Jean Charles²,Frenard Cécile³,Lecerf Philippe⁴,Khammari Amir³,Carlier Thomas²,Bodet‐Milin Caroline²,Dréno Brigitte³⁵^ORCID

Affiliation:

1. Department of Dermatology CIC 1413, IT services, CHU Nantes Nantes France

2. Department of Nuclear Medicine CHU Nantes Nantes France

3. INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302 Nantes Université Nantes France

4. IT Services, CHU Nantes Nantes France

5. Nantes Université, Univ Angers, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302 Nantes France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18501

Reference10 articles.

1. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial

2. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

3. Predictive value of FDG‐PET imaging for relapse in metastatic melanoma patients treated with immunotherapy

4. Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma

5. FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3